Literature DB >> 18289854

Identification of pyrrolo[2,1-f][1,2,4]triazine-based inhibitors of Met kinase.

Gretchen M Schroeder1, Xiao-Tao Chen, David K Williams, David S Nirschl, Zhen-Wei Cai, Donna Wei, John S Tokarski, Yongmi An, John Sack, Zhong Chen, Tram Huynh, Wayne Vaccaro, Michael Poss, Barri Wautlet, Johnni Gullo-Brown, Kristen Kellar, Veeraswamy Manne, John T Hunt, Tai W Wong, Louis J Lombardo, Joseph Fargnoli, Robert M Borzilleri.   

Abstract

An amide library derived from the pyrrolo[2,1-f][1,2,4]triazine scaffold led to the identification of modest inhibitors of Met kinase activity. Introduction of polar side chains at C-6 of the pyrrolotriazine core provided significant improvements in in vitro potency. The amide moiety could be replaced with acylurea and malonamide substituents to give compounds with improved potency in the Met-driven GTL-16 human gastric carcinoma cell line. Acylurea pyrrolotriazines with substitution at C-5 demonstrated single digit nanomolar kinase activity. X-ray crystallography revealed that the C-5 substituted pyrrolotriazines bind to the Met kinase domain in an ATP-competitive manner.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18289854     DOI: 10.1016/j.bmcl.2008.01.121

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Structure-Based Design of Type II Inhibitors Applied to Maternal Embryonic Leucine Zipper Kinase.

Authors:  Christopher N Johnson; Christophe Adelinet; Valerio Berdini; Lijs Beke; Pascal Bonnet; Dirk Brehmer; Frederick Calo; Joseph E Coyle; Phillip J Day; Martyn Frederickson; Eddy J E Freyne; Ron A H J Gilissen; Christopher C F Hamlett; Steven Howard; Lieven Meerpoel; Laurence Mevellec; Rachel McMenamin; Elisabeth Pasquier; Sahil Patel; David C Rees; Joannes T M Linders
Journal:  ACS Med Chem Lett       Date:  2014-05-23       Impact factor: 4.345

2.  Docking and quantitative structure-activity relationship studies for 3-fluoro-4-(pyrrolo[2,1-f][1,2,4]triazin-4-yloxy)aniline, 3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)aniline, and 4-(4-amino-2-fluorophenoxy)-2-pyridinylamine derivatives as c-Met kinase inhibitors.

Authors:  Julio Caballero; Miguel Quiliano; Jans H Alzate-Morales; Mirko Zimic; Eric Deharo
Journal:  J Comput Aided Mol Des       Date:  2011-04-13       Impact factor: 3.686

3.  Regio- and Diastereoselective 1,3-Dipolar Cycloadditions of 1,2,4-Triazin-1-ium Ylides: a Straightforward Synthetic Route to Polysubstituted Pyrrolo[2,1-f][1,2,4]triazines.

Authors:  Juraj Galeta; Veronika Šlachtová; Martin Dračínský; Milan Vrabel
Journal:  ACS Omega       Date:  2022-06-10

4.  Phenanthrotriazine Derivatives Containing Arylidine Hydrazone Moieties as Novel Potential c-Met Inhibitors with Anticancer Effect.

Authors:  Najmeh Edraki; Mohammad Hasan Jamei; Zahra Haghighijoo; Zahra Kayani; Elaheh Raufi; Masoomeh Eskandari; Maryam Firouzi; Hossein Sadeghpour; Ramin Miri; Mehdi Khoshneviszadeh; Omidreza Firuzi
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.